Premium
Opportunities for hepatitis B vaccination by SUD treatment programs
Author(s) -
Feinberg Judith,
Pearce Stacey
Publication year - 2021
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.33082
Subject(s) - pandemic , administration (probate law) , opioid epidemic , opioid overdose , public health , medicine , vaccination , drug overdose , session (web analytics) , covid-19 , political science , environmental health , economic growth , public administration , opioid , business , (+) naloxone , virology , poison control , nursing , advertising , law , economics , receptor , disease , pathology , infectious disease (medical specialty)
Despite significant effort from federal, state and local governments as well as health care providers, the opioid epidemic persists, with an increasing number of people who inject drugs (PWID). The COVID‐19 pandemic further exacerbated this trend; more than 87,000 Americans died of a drug overdose in the 12‐month period that ended in September 2020. Though the extent to which these public health crises intersect is difficult to gauge, there were notable spikes in overdose deaths in April and May of 2020 at the height of the pandemic. In remarks to the Joint Session of Congress on April 28, 2021, President Joe Biden acknowledged this as a priority topic for his administration, noting plans to make “critical investments to address the opioid crisis.”